GPCR (STOCKS)
Structure Therapeutics Inc. American Depositary Shares
$54.700000
+0.790000 (+1.47%)
Prev close: $53.910000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Raymond C. Stevens
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,338.75M
- Employees
- 183
- P/E (TTM)
- -17.50
- P/B (TTM)
- 2.83
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $257.81M |
| Research and Development | $294.24M |
| Operating Income/Loss | -$257.81M |
| Income/Loss From Continuing Operations After Tax | -$214.84M |
| Income/Loss From Continuing Operations Before Tax | -$214.13M |
| Income Tax Expense/Benefit | $702.00K |
| Net Income/Loss | -$214.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$214.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$214.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.01 |
| Diluted Earnings Per Share | -$1.01 |
| Basic Average Shares | 614,946,000 |
| Diluted Average Shares | 614,946,000 |
| Assets | $1.43B |
| Current Assets | $1.37B |
| Cash | $1.34B |
| Other Current Assets | $29.33M |
| Noncurrent Assets | $53.39M |
| Fixed Assets | $6.33M |
| Other Non-current Assets | $47.06M |
| Liabilities | $71.01M |
| Current Liabilities | $66.11M |
| Accounts Payable | $11.13M |
| Wages | $8.01M |
| Other Current Liabilities | $46.97M |
| Noncurrent Liabilities | $4.90M |
| Equity | $1.35B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.35B |
| Liabilities And Equity | $1.43B |
| Net Cash Flow From Operating Activities | -$220.29M |
| Net Cash Flow From Operating Activities, Continuing | -$220.29M |
| Net Cash Flow From Investing Activities | -$415.63M |
| Net Cash Flow From Investing Activities, Continuing | -$415.63M |
| Net Cash Flow From Financing Activities | $761.53M |
| Net Cash Flow From Financing Activities, Continuing | $761.53M |
| Net Cash Flow | $125.61M |
| Net Cash Flow, Continuing | $125.61M |
| Comprehensive Income/Loss | -$215.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$218.64M |
| Other Comprehensive Income/Loss | -$172.43M |
| Other Comprehensive Income/Loss Attributable To Parent | -$3.81M |